Composition of Faron Pharmaceutical's Shareholders' Nomination Board

About this update from Faron Pharmaceuticals Oy

[{"type":"text","content":"TURKU, FINLAND / ACCESS Newswire / December 17, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)(AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces that the following members have been re-elected by a meeting of the Company's five largest shareholders to Faron Pharmaceuticals Ltd's Shareholders' Nomination Board:","length":421,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Timo Syrjälä, representing himself (Chair)","length":42,"tagName":"p"}]},{"val":[{"type":"text","content":"Erkka Kohonen, representing Varma Mutual Pension Insurance Company, and","length":71,"tagName":"p"}]},{"val":[{"type":"text","content":"Joonas Haakana, representing UMO Capital","length":40,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":153,"olType":false},{"type":"text","content":"Faron's Shareholders' Nomination Board consists of three members, which represent the Company's shareholders. The Chair of Faron's Board of Directors, Mr. Tuomo Pätsi, will serve as an expert in the Nomination Board without being a member.","length":255,"tagName":"p"},{"type":"text","content":"The Shareholders' Nomination Board prepares and presents proposals to the Annual General Meeting on the number, composition and remuneration of the members of the Board as well as the Chair of the Board of Directors.","length":220,"tagName":"p"},{"type":"text","content":"For more information, please contact:","length":37,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"padding:1.5pt 3.0pt;width:51.28%;","val":[{"type":"text","content":"IR Partners, Finland(Media)Kare Laukkanen","length":44,"tagName":"p"}]},{"style":"padding:1.5pt 3.0pt;width:47.52%;","val":[{"type":"text","content":"+358 50 553 9535 / +44 7 469 766 [email protected]","length":65,"tagName":"p"}]}]},{"val":[{"style":"padding:1.5pt 3.0pt;width:51.28%;","val":[{"type":"text","content":"FINN Partners, US(Media) Alyssa Paldo","length":39,"tagName":"p"}]},{"style":"padding:1.5pt 3.0pt;width:47.52%;","val":[{"type":"text","content":"+1 847 791-8085 [email protected]","length":46,"tagName":"p"}]}]},{"val":[{"style":"padding:1.5pt 3.0pt;width:51.28%;","val":[{"type":"text","content":"Cairn Financial Advisers LLP(Nom...

More updates from Faron Pharmaceuticals Oy